Pier Capital’s PRA Health Sciences, Inc. PRAH Stock Holding History

Pier Capital’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-110,768	Closed	-$7.22M	–	143
2017 Q1	$7.22M	Sell	110,768 -107	-0.1%	-$6.3K	1.24%	15
2016 Q4	$6.11M	Sell	110,875 -3,316	-3%	-$182K	1.1%	21
2016 Q3	$6.45M	Sell	114,191 -6,841	-6%	-$335K	1.14%	13
2016 Q2	$5.05M	Buy	121,032 +42,406	+54%	+$1.95M	0.92%	77
2016 Q1	$3.36M	Sell	78,626 -8,105	-9%	-$342K	0.65%	88
2015 Q4	$3.93M	Sell	86,731 -2,160	-2%	-$90.7K	0.68%	83
2015 Q3	$3.45M	Buy	+88,891	New	+$3.56M	0.56%	88

Other funds holding PRAH

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Pier Capital's PRAH Position: Q2 2017 in Review

Pier Capital sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2017, closing a stake of 110,768 shares — an estimated $7.22M sold.

Pier Capital first reported a position in PRAH in Q3 2015 and held it in 7 quarters. The position peaked at $7.22M in Q1 2017. 236 funds tracked by Wall St. Rank hold PRAH as of Q2 2017.

Pier Capital reported no remaining PRA Health Sciences, Inc. position as of Q2 2017 after selling out during the quarter.
Pier Capital sold 110,768 PRA Health Sciences, Inc. shares in Q2 2017, an estimated $7.22M.
Pier Capital first reported a position in PRA Health Sciences, Inc. in Q3 2015 and held it in 7 quarters.
Pier Capital's PRA Health Sciences, Inc. position peaked at $7.22M in Q1 2017.
236 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2017.

Based on Pier Capital's 13F filing for Q2 2017, filed 9 Aug 2017.